首页 > 最新文献

Schizophrenia Bulletin最新文献

英文 中文
Evaluating Reduced Blood Monitoring Frequency and the Detection of Hematological Abnormalities in Clozapine-Treated Patients With Schizophrenia: A Chart Review Study From the COVID-19 Pandemic. 评估氯氮平治疗的精神分裂症患者血液监测频率的降低和血液异常的检测:COVID-19大流行病的病历回顾研究。
IF 5.3 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-07-10 DOI: 10.1093/schbul/sbae113
Helen Thai, Nicholas Preobrazenski, TiChen Hsieh, Carrie Robertson, Olabisi Owoeye

Background and hypothesis: In response to Health Canada's March 2020 directive, patients on clozapine for over 12 months were allowed to extend hematological testing intervals from 4 to 8 weeks during the COVID-19 pandemic. We hypothesized that this change would not affect the timely detection of hematological abnormalities in patients with severe mental illness.

Study design: A chart review was conducted of patients at the Royal Ottawa who were prescribed clozapine from March 2019 to March 2021. We analyzed clinical and hematological data from electronic health records and Clozaril Support and Assistance Network database to compare occurrences of hematological abnormalities [leukopenia (white blood cell count <3.5 × 109/L) and agranulocytosis (absolute neutrophil count <0.5 × 109/L)] from March 17, 2020 to March 16, 2021, between standard and extended monitoring protocols using binomial logistic and zero-inflated negative binomial regressions.

Study results: Of 621 patients, 196 were on extended blood monitoring, and 425 followed standard blood monitoring. Clozapine dose did not differ between groups (standard: 370 ± 201 mg; extended: 352 ± 172 mg; P = .14, ds = 0.10). Clozapine treatment duration up to March 2021 was 12.6 ± 8.3 years, with the extended group (10 ± 7.9 years) having a significantly (P < .01, ds = 0.50) shorter duration than the standard (14 ± 8.2 years). Extended monitoring did not significantly impact likelihood of detecting hematological abnormalities (OR = 0.83, 95% CI [0.58,1.41], P = .55) after controlling for age, sex, total bloodwork, and other psychotropics associated with neutrophil counts (ie, valproate, olanzapine). No patient on the extended regimen developed agranulocytosis.

Conclusions: Reducing blood monitoring frequency in patients on clozapine for more than 12 months did not compromise detection of hematological abnormalities.

背景与假设:为响应加拿大卫生部2020年3月的指令,在COVID-19大流行期间,允许使用氯氮平超过12个月的患者将血液检测间隔从4周延长至8周。我们假设这一变化不会影响及时发现重症精神病患者的血液学异常:我们对渥太华皇家医院在 2019 年 3 月至 2021 年 3 月期间处方氯氮平的患者进行了病历审查。我们分析了电子健康记录和氯氮平支持与援助网络数据库中的临床和血液学数据,以比较血液学异常[白细胞减少症(白细胞计数 研究结果:在621名患者中,196人接受了扩展血液监测,425人接受了标准血液监测。各组氯氮平剂量无差异(标准剂量:370 ± 201 毫克;延长剂量:352 ± 172 毫克;P = 0.14,ds = 0.10)。截至 2021 年 3 月,氯氮平的治疗时间为 12.6 ± 8.3 年,延长组(10 ± 7.9 年)的治疗时间明显长于标准组(P 结论:延长组的治疗时间明显短于标准组):减少使用氯氮平超过 12 个月的患者的血液监测频率不会影响血液异常的检测。
{"title":"Evaluating Reduced Blood Monitoring Frequency and the Detection of Hematological Abnormalities in Clozapine-Treated Patients With Schizophrenia: A Chart Review Study From the COVID-19 Pandemic.","authors":"Helen Thai, Nicholas Preobrazenski, TiChen Hsieh, Carrie Robertson, Olabisi Owoeye","doi":"10.1093/schbul/sbae113","DOIUrl":"https://doi.org/10.1093/schbul/sbae113","url":null,"abstract":"<p><strong>Background and hypothesis: </strong>In response to Health Canada's March 2020 directive, patients on clozapine for over 12 months were allowed to extend hematological testing intervals from 4 to 8 weeks during the COVID-19 pandemic. We hypothesized that this change would not affect the timely detection of hematological abnormalities in patients with severe mental illness.</p><p><strong>Study design: </strong>A chart review was conducted of patients at the Royal Ottawa who were prescribed clozapine from March 2019 to March 2021. We analyzed clinical and hematological data from electronic health records and Clozaril Support and Assistance Network database to compare occurrences of hematological abnormalities [leukopenia (white blood cell count <3.5 × 109/L) and agranulocytosis (absolute neutrophil count <0.5 × 109/L)] from March 17, 2020 to March 16, 2021, between standard and extended monitoring protocols using binomial logistic and zero-inflated negative binomial regressions.</p><p><strong>Study results: </strong>Of 621 patients, 196 were on extended blood monitoring, and 425 followed standard blood monitoring. Clozapine dose did not differ between groups (standard: 370 ± 201 mg; extended: 352 ± 172 mg; P = .14, ds = 0.10). Clozapine treatment duration up to March 2021 was 12.6 ± 8.3 years, with the extended group (10 ± 7.9 years) having a significantly (P < .01, ds = 0.50) shorter duration than the standard (14 ± 8.2 years). Extended monitoring did not significantly impact likelihood of detecting hematological abnormalities (OR = 0.83, 95% CI [0.58,1.41], P = .55) after controlling for age, sex, total bloodwork, and other psychotropics associated with neutrophil counts (ie, valproate, olanzapine). No patient on the extended regimen developed agranulocytosis.</p><p><strong>Conclusions: </strong>Reducing blood monitoring frequency in patients on clozapine for more than 12 months did not compromise detection of hematological abnormalities.</p>","PeriodicalId":21530,"journal":{"name":"Schizophrenia Bulletin","volume":null,"pages":null},"PeriodicalIF":5.3,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141564248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Echoes of Madness: My Journey With Schizophrenia. 疯狂的回声我的精神分裂之旅》。
IF 5.3 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-07-09 DOI: 10.1093/schbul/sbae124
Helene Cæcilie Mørck
{"title":"Echoes of Madness: My Journey With Schizophrenia.","authors":"Helene Cæcilie Mørck","doi":"10.1093/schbul/sbae124","DOIUrl":"https://doi.org/10.1093/schbul/sbae124","url":null,"abstract":"","PeriodicalId":21530,"journal":{"name":"Schizophrenia Bulletin","volume":null,"pages":null},"PeriodicalIF":5.3,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141564247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuroimage Analysis Methods and Artificial Intelligence Techniques for Reliable Biomarkers and Accurate Diagnosis of Schizophrenia: Achievements Made by Chinese Scholars Around the Past Decade. 神经影像分析方法和人工智能技术用于精神分裂症的可靠生物标记和准确诊断:近十年来中国学者取得的成就》。
IF 5.3 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-07-09 DOI: 10.1093/schbul/sbae110
Yuhui Du, Ju Niu, Ying Xing, Bang Li, Vince D Calhoun

Background and hypothesis: Schizophrenia (SZ) is characterized by significant cognitive and behavioral disruptions. Neuroimaging techniques, particularly magnetic resonance imaging (MRI), have been widely utilized to investigate biomarkers of SZ, distinguish SZ from healthy conditions or other mental disorders, and explore biotypes within SZ or across SZ and other mental disorders, which aim to promote the accurate diagnosis of SZ. In China, research on SZ using MRI has grown considerably in recent years.

Study design: The article reviews advanced neuroimaging and artificial intelligence (AI) methods using single-modal or multimodal MRI to reveal the mechanism of SZ and promote accurate diagnosis of SZ, with a particular emphasis on the achievements made by Chinese scholars around the past decade.

Study results: Our article focuses on the methods for capturing subtle brain functional and structural properties from the high-dimensional MRI data, the multimodal fusion and feature selection methods for obtaining important and sparse neuroimaging features, the supervised statistical analysis and classification for distinguishing disorders, and the unsupervised clustering and semi-supervised learning methods for identifying neuroimage-based biotypes. Crucially, our article highlights the characteristics of each method and underscores the interconnections among various approaches regarding biomarker extraction and neuroimage-based diagnosis, which is beneficial not only for comprehending SZ but also for exploring other mental disorders.

Conclusions: We offer a valuable review of advanced neuroimage analysis and AI methods primarily focused on SZ research by Chinese scholars, aiming to promote the diagnosis, treatment, and prevention of SZ, as well as other mental disorders, both within China and internationally.

背景与假设:精神分裂症(SZ)以严重的认知和行为障碍为特征。神经影像学技术,尤其是磁共振成像(MRI),已被广泛应用于研究精神分裂症的生物标志物,区分精神分裂症与健康状况或其他精神障碍,探索精神分裂症内部或精神分裂症与其他精神障碍之间的生物类型,从而促进对精神分裂症的准确诊断。在中国,近年来利用核磁共振成像对SZ的研究有了长足的发展:研究设计:文章回顾了利用单模态或多模态核磁共振成像技术揭示SZ发病机制、促进SZ准确诊断的先进神经影像学和人工智能(AI)方法,特别强调了中国学者近十年来所取得的成果:研究成果:本文主要介绍了从高维MRI数据中捕捉细微脑功能和结构特性的方法、获取重要和稀疏神经影像特征的多模态融合和特征选择方法、区分疾病的监督统计分析和分类方法,以及识别基于神经影像的生物分型的无监督聚类和半监督学习方法。最重要的是,我们的文章突出了每种方法的特点,强调了生物标记物提取和基于神经影像诊断的各种方法之间的相互联系,这不仅有利于理解 SZ,也有利于探索其他精神疾病:我们对国内学者主要针对 SZ 研究的先进神经影像分析和人工智能方法进行了有价值的综述,旨在促进国内外对 SZ 以及其他精神障碍的诊断、治疗和预防。
{"title":"Neuroimage Analysis Methods and Artificial Intelligence Techniques for Reliable Biomarkers and Accurate Diagnosis of Schizophrenia: Achievements Made by Chinese Scholars Around the Past Decade.","authors":"Yuhui Du, Ju Niu, Ying Xing, Bang Li, Vince D Calhoun","doi":"10.1093/schbul/sbae110","DOIUrl":"https://doi.org/10.1093/schbul/sbae110","url":null,"abstract":"<p><strong>Background and hypothesis: </strong>Schizophrenia (SZ) is characterized by significant cognitive and behavioral disruptions. Neuroimaging techniques, particularly magnetic resonance imaging (MRI), have been widely utilized to investigate biomarkers of SZ, distinguish SZ from healthy conditions or other mental disorders, and explore biotypes within SZ or across SZ and other mental disorders, which aim to promote the accurate diagnosis of SZ. In China, research on SZ using MRI has grown considerably in recent years.</p><p><strong>Study design: </strong>The article reviews advanced neuroimaging and artificial intelligence (AI) methods using single-modal or multimodal MRI to reveal the mechanism of SZ and promote accurate diagnosis of SZ, with a particular emphasis on the achievements made by Chinese scholars around the past decade.</p><p><strong>Study results: </strong>Our article focuses on the methods for capturing subtle brain functional and structural properties from the high-dimensional MRI data, the multimodal fusion and feature selection methods for obtaining important and sparse neuroimaging features, the supervised statistical analysis and classification for distinguishing disorders, and the unsupervised clustering and semi-supervised learning methods for identifying neuroimage-based biotypes. Crucially, our article highlights the characteristics of each method and underscores the interconnections among various approaches regarding biomarker extraction and neuroimage-based diagnosis, which is beneficial not only for comprehending SZ but also for exploring other mental disorders.</p><p><strong>Conclusions: </strong>We offer a valuable review of advanced neuroimage analysis and AI methods primarily focused on SZ research by Chinese scholars, aiming to promote the diagnosis, treatment, and prevention of SZ, as well as other mental disorders, both within China and internationally.</p>","PeriodicalId":21530,"journal":{"name":"Schizophrenia Bulletin","volume":null,"pages":null},"PeriodicalIF":5.3,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141564249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
We All Want to Be in Music Videos, Honey. 我们都想出演音乐录影带,亲爱的。
IF 5.3 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-07-09 DOI: 10.1093/schbul/sbae122
Sarah An Myers
{"title":"We All Want to Be in Music Videos, Honey.","authors":"Sarah An Myers","doi":"10.1093/schbul/sbae122","DOIUrl":"https://doi.org/10.1093/schbul/sbae122","url":null,"abstract":"","PeriodicalId":21530,"journal":{"name":"Schizophrenia Bulletin","volume":null,"pages":null},"PeriodicalIF":5.3,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141564250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting Clinical Improvement in Early Psychosis Using Circuit-Based Resting-State Functional Magnetic Resonance Imaging. 利用基于电路的静息状态功能磁共振成像预测早期精神病的临床改善
IF 5.3 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-07-09 DOI: 10.1093/schbul/sbae117
Jason Smucny, Tyler A Lesh, Marina D Albuquerque, Joshua P Rhilinger, Cameron S Carter

Background and hypothesis: Identifying biomarkers that predict treatment response in early psychosis (EP) is a priority for psychiatry research. Previous work suggests that resting-state connectivity biomarkers may have promise as predictive measures, although prior results vary considerably in direction and magnitude. Here, we evaluated the relationship between intrinsic functional connectivity of the attention, default mode, and salience resting-state networks and 12-month clinical improvement in EP.

Study design: Fifty-eight individuals with EP (less than 2 years from illness onset, 35 males, average age 20 years) had baseline and follow-up clinical data and were included in the final sample. Of these, 30 EPs showed greater than 20% improvement in Brief Psychiatric Rating Scale (BPRS) total score at follow-up and were classified as "Improvers."

Study results: The overall logistic regression predicting Improver status was significant (χ2 = 23.66, Nagelkerke's R2 = 0.45, P < .001, with 85% concordance). Significant individual predictors of Improver status included higher default mode within-network connectivity, higher attention-default mode between-network connectivity, and higher attention-salience between-network connectivity. Including baseline BPRS as a predictor increased model significance and concordance to 92%, and the model was not significantly influenced by the dose of antipsychotic medication (chlorpromazine equivalents). Linear regression models predicting percent change in BPRS were also significant.

Conclusions: Overall, these results suggest that resting-state functional magnetic resonance imaging connectivity may serve as a useful biomarker of clinical outcomes in recent-onset psychosis.

背景和假设:确定能预测早期精神病(EP)治疗反应的生物标志物是精神病学研究的当务之急。之前的研究表明,静息态连接生物标志物可能具有预测作用,尽管之前的研究结果在方向和幅度上存在很大差异。在此,我们评估了注意力、默认模式和显著性静息态网络的内在功能连通性与 EP 12 个月临床改善之间的关系:研究设计:58 名 EP 患者(发病不足 2 年,35 名男性,平均年龄 20 岁)拥有基线和随访临床数据,并被纳入最终样本。其中,30 名 EP 患者的简明精神病评定量表(BPRS)总分在随访时改善了 20% 以上,被归类为 "改善者":预测 "改善者 "状态的总体逻辑回归结果是显著的(χ2 = 23.66,Nagelkerke's R2 = 0.45,P 结论:这些结果表明,静息疗法对 "改善者 "状态的预测是显著的:总之,这些结果表明,静息态功能磁共振成像连通性可作为新近发病的精神病患者临床预后的有用生物标志物。
{"title":"Predicting Clinical Improvement in Early Psychosis Using Circuit-Based Resting-State Functional Magnetic Resonance Imaging.","authors":"Jason Smucny, Tyler A Lesh, Marina D Albuquerque, Joshua P Rhilinger, Cameron S Carter","doi":"10.1093/schbul/sbae117","DOIUrl":"https://doi.org/10.1093/schbul/sbae117","url":null,"abstract":"<p><strong>Background and hypothesis: </strong>Identifying biomarkers that predict treatment response in early psychosis (EP) is a priority for psychiatry research. Previous work suggests that resting-state connectivity biomarkers may have promise as predictive measures, although prior results vary considerably in direction and magnitude. Here, we evaluated the relationship between intrinsic functional connectivity of the attention, default mode, and salience resting-state networks and 12-month clinical improvement in EP.</p><p><strong>Study design: </strong>Fifty-eight individuals with EP (less than 2 years from illness onset, 35 males, average age 20 years) had baseline and follow-up clinical data and were included in the final sample. Of these, 30 EPs showed greater than 20% improvement in Brief Psychiatric Rating Scale (BPRS) total score at follow-up and were classified as \"Improvers.\"</p><p><strong>Study results: </strong>The overall logistic regression predicting Improver status was significant (χ2 = 23.66, Nagelkerke's R2 = 0.45, P < .001, with 85% concordance). Significant individual predictors of Improver status included higher default mode within-network connectivity, higher attention-default mode between-network connectivity, and higher attention-salience between-network connectivity. Including baseline BPRS as a predictor increased model significance and concordance to 92%, and the model was not significantly influenced by the dose of antipsychotic medication (chlorpromazine equivalents). Linear regression models predicting percent change in BPRS were also significant.</p><p><strong>Conclusions: </strong>Overall, these results suggest that resting-state functional magnetic resonance imaging connectivity may serve as a useful biomarker of clinical outcomes in recent-onset psychosis.</p>","PeriodicalId":21530,"journal":{"name":"Schizophrenia Bulletin","volume":null,"pages":null},"PeriodicalIF":5.3,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141559666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations of Cognitive Expectancies With Auditory Hallucinations and Hallucinatory-Like Experiences in Patients With Schizophrenia. 认知期望与精神分裂症患者的听觉幻觉和类似幻觉的体验之间的关联》(Cognitive Expectancies with Auditory Hallucinations and Hallucinatory-Like Experiences in Patients with Schizophrenia)。
IF 5.3 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-07-09 DOI: 10.1093/schbul/sbae115
Joachim Kowalski, Małgorzata Dąbkowska, Adrianna Aleksandrowicz, Michał Jarkiewicz, Frank Larøi, Łukasz Gawęda

Background: Various neurocognitive models explore perceptual distortions and hallucinations in schizophrenia and the general population. A variant of predictive coding account suggests that strong priors, like cognitive expectancy, may influence perception. This study examines if stronger cognitive expectancies result in more auditory false percepts in clinical and healthy control groups, investigates group differences, and explores the association between false percepts and hallucinations.

Study design: Patients diagnosed with schizophrenia with current auditory hallucinations (n = 51) and without hallucinations (n = 66) and healthy controls (n = 51) underwent the False Perception Task under various expectancy conditions. All groups were examined for the presence and severity of hallucinations or hallucinatory-like experiences.

Study results: We observed a main effect of condition across all groups, ie, the stronger the cognitive expectancy, the greater the ratio of auditory false percepts. However, there was no group effect for the ratio of auditory false percepts. Despite modest pairwise correlations in the hallucinating group, the ratio of auditory false percepts was not predicted by levels of hallucinations and hallucinatory-like experiences in a linear mixed model.

Conclusions: The current study demonstrates that strong priors in the form of cognitive expectancies affect perception and play a role in perceptual disturbances. There is also a tentative possibility that overreliance on strong priors may be associated with hallucinations in currently hallucinating subjects. Possible, avoidable confounding factors are discussed in detail.

背景:各种神经认知模型探讨了精神分裂症和普通人群中的知觉歪曲和幻觉。预测编码的一种变体认为,强烈的先验(如认知预期)可能会影响知觉。本研究探讨了较强的认知预期是否会导致临床组和健康对照组出现更多的听觉错误知觉,调查了组间差异,并探讨了错误知觉与幻觉之间的关联:研究设计:被诊断为精神分裂症且目前有幻听的患者(n = 51)和无幻听的患者(n = 66)以及健康对照组(n = 51)在不同期望条件下接受了假知觉任务。所有组别均接受了幻觉或类似幻觉体验的存在和严重程度的检查:我们在所有组别中观察到了条件的主效应,即认知期望越强,听觉假知觉的比例越大。但是,听觉错误知觉的比率没有组间效应。尽管在幻觉组中存在适度的成对相关性,但在线性混合模型中,幻觉水平和类似幻觉的经历并不能预测听觉错误知觉的比率:当前的研究表明,认知预期形式的强先验会影响知觉,并在知觉障碍中发挥作用。还有一种初步的可能性是,过度依赖强先验可能与当前出现幻觉的受试者的幻觉有关。本文详细讨论了可能的、可避免的混杂因素。
{"title":"Associations of Cognitive Expectancies With Auditory Hallucinations and Hallucinatory-Like Experiences in Patients With Schizophrenia.","authors":"Joachim Kowalski, Małgorzata Dąbkowska, Adrianna Aleksandrowicz, Michał Jarkiewicz, Frank Larøi, Łukasz Gawęda","doi":"10.1093/schbul/sbae115","DOIUrl":"https://doi.org/10.1093/schbul/sbae115","url":null,"abstract":"<p><strong>Background: </strong>Various neurocognitive models explore perceptual distortions and hallucinations in schizophrenia and the general population. A variant of predictive coding account suggests that strong priors, like cognitive expectancy, may influence perception. This study examines if stronger cognitive expectancies result in more auditory false percepts in clinical and healthy control groups, investigates group differences, and explores the association between false percepts and hallucinations.</p><p><strong>Study design: </strong>Patients diagnosed with schizophrenia with current auditory hallucinations (n = 51) and without hallucinations (n = 66) and healthy controls (n = 51) underwent the False Perception Task under various expectancy conditions. All groups were examined for the presence and severity of hallucinations or hallucinatory-like experiences.</p><p><strong>Study results: </strong>We observed a main effect of condition across all groups, ie, the stronger the cognitive expectancy, the greater the ratio of auditory false percepts. However, there was no group effect for the ratio of auditory false percepts. Despite modest pairwise correlations in the hallucinating group, the ratio of auditory false percepts was not predicted by levels of hallucinations and hallucinatory-like experiences in a linear mixed model.</p><p><strong>Conclusions: </strong>The current study demonstrates that strong priors in the form of cognitive expectancies affect perception and play a role in perceptual disturbances. There is also a tentative possibility that overreliance on strong priors may be associated with hallucinations in currently hallucinating subjects. Possible, avoidable confounding factors are discussed in detail.</p>","PeriodicalId":21530,"journal":{"name":"Schizophrenia Bulletin","volume":null,"pages":null},"PeriodicalIF":5.3,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141564246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A 10-Year Longitudinal Study of Brain Cortical Thickness in People with First-Episode Psychosis Using Normative Models. 使用常模对首发精神病患者大脑皮层厚度进行为期 10 年的纵向研究。
IF 5.3 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-07-05 DOI: 10.1093/schbul/sbae107
Pierre Berthet, Beathe C Haatveit, Rikka Kjelkenes, Amanda Worker, Seyed Mostafa Kia, Thomas Wolfers, Saige Rutherford, Dag Alnaes, Richard Dinga, Mads L Pedersen, Andreas Dahl, Sara Fernandez-Cabello, Paola Dazzan, Ingrid Agartz, Ragnar Nesvåg, Torill Ueland, Ole A Andreassen, Carmen Simonsen, Lars T Westlye, Ingrid Melle, Andre Marquand

Background: Clinical forecasting models have potential to optimize treatment and improve outcomes in psychosis, but predicting long-term outcomes is challenging and long-term follow-up data are scarce. In this 10-year longitudinal study, we aimed to characterize the temporal evolution of cortical correlates of psychosis and their associations with symptoms.

Design: Structural magnetic resonance imaging (MRI) from people with first-episode psychosis and controls (n = 79 and 218) were obtained at enrollment, after 12 months (n = 67 and 197), and 10 years (n = 23 and 77), within the Thematically Organized Psychosis (TOP) study. Normative models for cortical thickness estimated on public MRI datasets (n = 42 983) were applied to TOP data to obtain deviation scores for each region and timepoint. Positive and Negative Syndrome Scale (PANSS) scores were acquired at each timepoint along with registry data. Linear mixed effects models assessed effects of diagnosis, time, and their interactions on cortical deviations plus associations with symptoms.

Results: LMEs revealed conditional main effects of diagnosis and time × diagnosis interactions in a distributed cortical network, where negative deviations in patients attenuate over time. In patients, symptoms also attenuate over time. LMEs revealed effects of anterior cingulate on PANSS total, and insular and orbitofrontal regions on PANSS negative scores.

Conclusions: This long-term longitudinal study revealed a distributed pattern of cortical differences which attenuated over time together with a reduction in symptoms. These findings are not in line with a simple neurodegenerative account of schizophrenia, and deviations from normative models offer a promising avenue to develop biomarkers to track clinical trajectories over time.

背景:临床预测模型具有优化治疗和改善精神病预后的潜力,但预测长期预后具有挑战性,而且长期随访数据很少。在这项为期 10 年的纵向研究中,我们旨在描述精神病皮质相关因素的时间演变及其与症状的关联:结构磁共振成像(MRI):在 "主题性有组织精神病(TOP)"研究中,我们分别在入组时、12 个月后(67 人和 197 人)以及 10 年后(23 人和 77 人)获得了首发精神病患者和对照组(79 人和 218 人)的结构磁共振成像(MRI)。根据公共核磁共振成像数据集(n = 42 983)估算的皮质厚度标准模型被应用到 TOP 数据中,以获得每个区域和时间点的偏差分数。每个时间点的阳性和阴性综合征量表(PANSS)评分与登记数据一起获得。线性混合效应模型评估了诊断、时间及其交互作用对皮层偏差的影响以及与症状的关联:线性混合效应模型揭示了分布式皮层网络中诊断和时间×诊断交互作用的条件主效应,其中患者的负偏差随着时间的推移而减弱。患者的症状也随着时间的推移而减弱。LMEs显示了前扣带回对PANSS总分的影响,以及岛叶区和眶额区对PANSS负分的影响:这项长期纵向研究揭示了皮质差异的分布模式,这种差异随着时间的推移而减弱,症状也随之减轻。这些发现与精神分裂症的简单神经退行性解释不符,与常模的偏差为开发生物标记物以追踪临床轨迹提供了一个很有前景的途径。
{"title":"A 10-Year Longitudinal Study of Brain Cortical Thickness in People with First-Episode Psychosis Using Normative Models.","authors":"Pierre Berthet, Beathe C Haatveit, Rikka Kjelkenes, Amanda Worker, Seyed Mostafa Kia, Thomas Wolfers, Saige Rutherford, Dag Alnaes, Richard Dinga, Mads L Pedersen, Andreas Dahl, Sara Fernandez-Cabello, Paola Dazzan, Ingrid Agartz, Ragnar Nesvåg, Torill Ueland, Ole A Andreassen, Carmen Simonsen, Lars T Westlye, Ingrid Melle, Andre Marquand","doi":"10.1093/schbul/sbae107","DOIUrl":"https://doi.org/10.1093/schbul/sbae107","url":null,"abstract":"<p><strong>Background: </strong>Clinical forecasting models have potential to optimize treatment and improve outcomes in psychosis, but predicting long-term outcomes is challenging and long-term follow-up data are scarce. In this 10-year longitudinal study, we aimed to characterize the temporal evolution of cortical correlates of psychosis and their associations with symptoms.</p><p><strong>Design: </strong>Structural magnetic resonance imaging (MRI) from people with first-episode psychosis and controls (n = 79 and 218) were obtained at enrollment, after 12 months (n = 67 and 197), and 10 years (n = 23 and 77), within the Thematically Organized Psychosis (TOP) study. Normative models for cortical thickness estimated on public MRI datasets (n = 42 983) were applied to TOP data to obtain deviation scores for each region and timepoint. Positive and Negative Syndrome Scale (PANSS) scores were acquired at each timepoint along with registry data. Linear mixed effects models assessed effects of diagnosis, time, and their interactions on cortical deviations plus associations with symptoms.</p><p><strong>Results: </strong>LMEs revealed conditional main effects of diagnosis and time × diagnosis interactions in a distributed cortical network, where negative deviations in patients attenuate over time. In patients, symptoms also attenuate over time. LMEs revealed effects of anterior cingulate on PANSS total, and insular and orbitofrontal regions on PANSS negative scores.</p><p><strong>Conclusions: </strong>This long-term longitudinal study revealed a distributed pattern of cortical differences which attenuated over time together with a reduction in symptoms. These findings are not in line with a simple neurodegenerative account of schizophrenia, and deviations from normative models offer a promising avenue to develop biomarkers to track clinical trajectories over time.</p>","PeriodicalId":21530,"journal":{"name":"Schizophrenia Bulletin","volume":null,"pages":null},"PeriodicalIF":5.3,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141545213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Positive, Negative, and Disorganized Schizotypy With the Temporal Dynamics of Schizotypic Experiences in Daily Life. 积极、消极和无组织分裂型与日常生活中分裂型经历的时间动态相关性。
IF 5.3 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-07-04 DOI: 10.1093/schbul/sbae112
Kathryn C Kemp, Sarah H Sperry, Laura Hernández, Neus Barrantes-Vidal, Thomas R Kwapil

Background and hypothesis: Schizotypy is a useful and unifying construct for examining the etiology, development, and expression of schizophrenia-spectrum psychopathology. The positive, negative, and disorganized schizotypy dimensions are associated with distinct patterns of schizophrenia-spectrum symptoms and impairment. Furthermore, they are differentiated by mean levels of psychotic-like, suspicious, negative, and disorganized schizotypic experiences in daily life, and by temporal dynamics of affect. The schizotypy dimensions were thus hypothesized to be differentiated by the temporal dynamics of schizotypic experiences in daily life.

Study design: The present study employed experience sampling methodology in a large nonclinically ascertained sample (n = 693) to examine the associations of multidimensional schizotypy with psychotic-like, suspicious, negative, and disorganized schizotypic experiences in daily life, as well as with their temporal dynamics (variability, reactivity, inertia, and instability).

Study results: We replicated the mean-level associations between multidimensional schizotypy and schizotypic experiences in daily life. Furthermore, positive, negative, and disorganized schizotypy demonstrated hypothesized, differential patterns of temporal dynamics of schizotypic experiences. Disorganized schizotypy demonstrated the most robust associations, including intensity, variability, and inertia of disorganized schizotypic experiences. Disorganized schizotypy also moderated reactivity of psychotic-like and disorganized schizotypic experiences following previously reported stress. Positive schizotypy was associated with intensity and variability of psychotic-like experiences. Negative schizotypy was associated with intensity and variability of negative schizotypic experiences.

Conclusions: The findings indicate that schizotypy dimensions can be differentiated by both mean levels and temporal patterns of psychotic-like, suspicious, negative, and disorganized schizotypic experiences in daily life, with disorganized schizotypy uniquely characterized by stress reactivity.

背景与假设:分裂型是研究精神分裂症谱系精神病理学的病因、发展和表现的一个有用的统一概念。积极型、消极型和混乱型精神分裂症与精神分裂症谱症状和损害的不同模式有关。此外,它们还可以通过日常生活中精神病样、多疑、阴性和无序精神分裂症体验的平均水平以及情感的时间动态加以区分。因此,我们假设精神分裂症各维度可通过日常生活中精神分裂症体验的时间动态来区分:研究设计:本研究采用经验抽样方法,在一个非临床确定的大型样本(n = 693)中考察了多维精神分裂症与日常生活中精神病样、多疑、消极和无组织精神分裂症体验的关联,以及与这些体验的时间动态(可变性、反应性、惯性和不稳定性)的关联:研究结果:我们重复了多维精神分裂症与日常生活中的精神分裂症经历之间的平均水平关联。此外,积极型、消极型和无组织型精神分裂症表现出了假设的、不同的精神分裂症体验时间动态模式。无组织分裂型表现出了最强有力的关联,包括无组织分裂型体验的强度、可变性和惯性。在之前报告的压力之后,无序分裂型还能调节精神病样和无序分裂型体验的反应性。阳性分裂型与精神病样体验的强度和变异性有关。结论:研究结果表明,精神分裂症可以通过日常生活中精神病样、多疑、消极和无组织精神分裂症体验的平均水平和时间模式来区分,其中无组织精神分裂症的独特特征是应激反应性。
{"title":"Association of Positive, Negative, and Disorganized Schizotypy With the Temporal Dynamics of Schizotypic Experiences in Daily Life.","authors":"Kathryn C Kemp, Sarah H Sperry, Laura Hernández, Neus Barrantes-Vidal, Thomas R Kwapil","doi":"10.1093/schbul/sbae112","DOIUrl":"https://doi.org/10.1093/schbul/sbae112","url":null,"abstract":"<p><strong>Background and hypothesis: </strong>Schizotypy is a useful and unifying construct for examining the etiology, development, and expression of schizophrenia-spectrum psychopathology. The positive, negative, and disorganized schizotypy dimensions are associated with distinct patterns of schizophrenia-spectrum symptoms and impairment. Furthermore, they are differentiated by mean levels of psychotic-like, suspicious, negative, and disorganized schizotypic experiences in daily life, and by temporal dynamics of affect. The schizotypy dimensions were thus hypothesized to be differentiated by the temporal dynamics of schizotypic experiences in daily life.</p><p><strong>Study design: </strong>The present study employed experience sampling methodology in a large nonclinically ascertained sample (n = 693) to examine the associations of multidimensional schizotypy with psychotic-like, suspicious, negative, and disorganized schizotypic experiences in daily life, as well as with their temporal dynamics (variability, reactivity, inertia, and instability).</p><p><strong>Study results: </strong>We replicated the mean-level associations between multidimensional schizotypy and schizotypic experiences in daily life. Furthermore, positive, negative, and disorganized schizotypy demonstrated hypothesized, differential patterns of temporal dynamics of schizotypic experiences. Disorganized schizotypy demonstrated the most robust associations, including intensity, variability, and inertia of disorganized schizotypic experiences. Disorganized schizotypy also moderated reactivity of psychotic-like and disorganized schizotypic experiences following previously reported stress. Positive schizotypy was associated with intensity and variability of psychotic-like experiences. Negative schizotypy was associated with intensity and variability of negative schizotypic experiences.</p><p><strong>Conclusions: </strong>The findings indicate that schizotypy dimensions can be differentiated by both mean levels and temporal patterns of psychotic-like, suspicious, negative, and disorganized schizotypic experiences in daily life, with disorganized schizotypy uniquely characterized by stress reactivity.</p>","PeriodicalId":21530,"journal":{"name":"Schizophrenia Bulletin","volume":null,"pages":null},"PeriodicalIF":5.3,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141498883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National Institute of Mental Health Support for Cognitive Treatment Development in Schizophrenia: A Narrative Review 国家精神卫生研究所对精神分裂症认知治疗发展的支持:叙述性综述
IF 6.6 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-06-28 DOI: 10.1093/schbul/sbae109
Robert K Heinssen, Sarah E Morris, Joel T Sherrill
For several decades the National Institute of Mental Health (NIMH) has supported basic and translational research into cognitive impairment in schizophrenia. This article describes the Institute’s ongoing commitment to cognitive assessment and intervention research, as reflected by three signature initiatives—Measurement and Treatment Research to Improve Cognition in Schizophrenia; Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia; and Research Domain Criteria—and related funding announcements that span basic experimental studies, efficacy and comparative effectiveness trials, and implementation research designed to promote cognitive healthcare in real-world treatment settings. We discuss how trends in science and public health policy since the early 2000s have influenced NIMH treatment development activities, resulting in greater attention to (1) inclusive teams that reflect end-user perspectives on the utility of proposed studies; (2) measurement of discrete neurocognitive processes to inform targeted interventions; (3) clinical trials that produce useful information about putative illness mechanisms, promising treatment targets, and downstream clinical effects; and (4) “productive urgency” in pursuing feasible and effective cognitive interventions for psychosis. Programs employing these principles have catalyzed cognitive measurement, drug development, and behavioral intervention approaches that aim to improve neurocognition and community functioning among persons with schizophrenia. NIMH will maintain support for innovative and impactful investigator-initiated research that advances patient-centered, clinically effective, and continuously improving cognitive health care for persons with psychotic disorders.
几十年来,美国国立精神卫生研究所(NIMH)一直支持对精神分裂症认知障碍的基础研究和转化研究。本文介绍了该研究所对认知评估和干预研究的持续承诺,这体现在三个标志性倡议--改善精神分裂症认知的测量和治疗研究、改善精神分裂症认知的认知神经科学治疗研究和研究领域标准--以及相关的资助公告中,这些研究涵盖了基础实验研究、疗效和比较效益试验,以及旨在促进实际治疗环境中认知保健的实施研究。我们讨论了自21世纪初以来科学和公共卫生政策的发展趋势如何影响了NIMH的治疗开发活动,从而使其更加关注:(1)反映最终用户对拟议研究效用的看法的包容性团队;(2)对离散神经认知过程的测量,为有针对性的干预措施提供信息;(3)临床试验,为假定的疾病机制、有希望的治疗目标和下游临床效果提供有用的信息;以及(4)在寻求对精神病进行可行而有效的认知干预时的 "生产紧迫性"。采用这些原则的计划促进了认知测量、药物开发和行为干预方法,旨在改善精神分裂症患者的神经认知和社区功能。NIMH 将继续支持由研究者发起的具有创新性和影响力的研究,以促进以患者为中心、临床有效和不断改进的精神病患者认知保健。
{"title":"National Institute of Mental Health Support for Cognitive Treatment Development in Schizophrenia: A Narrative Review","authors":"Robert K Heinssen, Sarah E Morris, Joel T Sherrill","doi":"10.1093/schbul/sbae109","DOIUrl":"https://doi.org/10.1093/schbul/sbae109","url":null,"abstract":"For several decades the National Institute of Mental Health (NIMH) has supported basic and translational research into cognitive impairment in schizophrenia. This article describes the Institute’s ongoing commitment to cognitive assessment and intervention research, as reflected by three signature initiatives—Measurement and Treatment Research to Improve Cognition in Schizophrenia; Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia; and Research Domain Criteria—and related funding announcements that span basic experimental studies, efficacy and comparative effectiveness trials, and implementation research designed to promote cognitive healthcare in real-world treatment settings. We discuss how trends in science and public health policy since the early 2000s have influenced NIMH treatment development activities, resulting in greater attention to (1) inclusive teams that reflect end-user perspectives on the utility of proposed studies; (2) measurement of discrete neurocognitive processes to inform targeted interventions; (3) clinical trials that produce useful information about putative illness mechanisms, promising treatment targets, and downstream clinical effects; and (4) “productive urgency” in pursuing feasible and effective cognitive interventions for psychosis. Programs employing these principles have catalyzed cognitive measurement, drug development, and behavioral intervention approaches that aim to improve neurocognition and community functioning among persons with schizophrenia. NIMH will maintain support for innovative and impactful investigator-initiated research that advances patient-centered, clinically effective, and continuously improving cognitive health care for persons with psychotic disorders.","PeriodicalId":21530,"journal":{"name":"Schizophrenia Bulletin","volume":null,"pages":null},"PeriodicalIF":6.6,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141462712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychosocial Interventions for Individuals With Comorbid Psychosis and Substance Use Disorders: Systematic Review and Meta-analysis of Randomized Studies 对合并有精神病和药物使用障碍者的社会心理干预:随机研究的系统回顾和元分析
IF 6.6 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-06-28 DOI: 10.1093/schbul/sbae101
Salsabil Siddiqui, Dhvani Mehta, Alexandria Coles, Peter Selby, Marco Solmi, David Castle
Background and Hypothesis Substance use is highly prevalent among people with schizophrenia (SCZ) and related disorders, however, there is no broad-spectrum pharmacotherapy that concurrently addresses both addiction and psychotic symptoms. Psychosocial (PS) interventions, which have yielded promising results in treating psychosis and substance dependence separately, demonstrate potential but have not been systematically evaluated when combined. Study Design Systematic review and random-effects meta-analyses of randomized controlled trials (RCTs) investigating PS interventions for individuals with comorbid substance use and psychotic disorders, encompassing SCZ and schizophrenia spectrum disorders (SSD). We included relevant studies published from MEDLINE, PsycINFO, and Google Scholar through May 2023. Study Results We included 35 RCTs (5176 participants total; approximately 2840 with SSD). Intervention durations ranged from 30 min to 3 years. Meta-analysis did not identify a statistically significant pooled PS intervention effect on the main primary outcome, substance use (18 studies; 803 intervention, 733 control participants; standardized mean difference, −0.05 standard deviation [SD]; 95% CI, −0.16, 0.07 SD; I2 = 18%). PS intervention effects on other outcomes were also not statistically significant. Overall GRADE certainty of evidence was low. Conclusions At present, the literature lacks sufficient evidence supporting the use of PS interventions as opposed to alternative therapeutic approaches for significantly improving substance use, symptomatology, or functioning in people with SCZ and related disorders. However, firm conclusions were precluded by low certainty of evidence. Further RCTs are needed to determine the efficacy of PS treatments for people with dual-diagnoses (DD), either alone or in combination with pharmacotherapy.
背景与假设 物质使用在精神分裂症(SCZ)及相关疾病患者中非常普遍,然而,目前还没有一种广谱药物疗法可以同时治疗成瘾和精神病症状。社会心理(PS)干预在单独治疗精神病和药物依赖方面取得了可喜的成果,显示出了潜力,但尚未对其结合使用进行系统评估。研究设计 对随机对照试验(RCT)进行系统回顾和随机效应荟萃分析,调查针对合并药物使用和精神障碍(包括精神分裂症和精神分裂症谱系障碍)患者的 PS 干预措施。我们纳入了截至 2023 年 5 月在 MEDLINE、PsycINFO 和 Google Scholar 上发表的相关研究。研究结果 我们纳入了 35 项 RCT(共 5176 人参与;约 2840 人患有 SSD)。干预持续时间从 30 分钟到 3 年不等。Meta 分析未发现 PS 干预对主要主要结果(药物使用)有显著的统计学意义(18 项研究;803 名干预参与者,733 名对照参与者;标准化平均差,-0.05 标准差 [SD];95% CI,-0.16,0.07 SD;I2 = 18%)。PS 干预对其他结果的影响也没有统计学意义。总体 GRADE 证据确定性较低。结论 目前,文献缺乏足够的证据证明,相对于其他治疗方法,PS干预能显著改善SCZ及相关障碍患者的药物使用、症状或功能。然而,由于证据的确定性较低,因此无法得出肯定的结论。需要进一步开展研究性试验,以确定 PS 治疗对双重诊断(DD)患者的疗效,无论是单独使用还是与药物治疗相结合。
{"title":"Psychosocial Interventions for Individuals With Comorbid Psychosis and Substance Use Disorders: Systematic Review and Meta-analysis of Randomized Studies","authors":"Salsabil Siddiqui, Dhvani Mehta, Alexandria Coles, Peter Selby, Marco Solmi, David Castle","doi":"10.1093/schbul/sbae101","DOIUrl":"https://doi.org/10.1093/schbul/sbae101","url":null,"abstract":"Background and Hypothesis Substance use is highly prevalent among people with schizophrenia (SCZ) and related disorders, however, there is no broad-spectrum pharmacotherapy that concurrently addresses both addiction and psychotic symptoms. Psychosocial (PS) interventions, which have yielded promising results in treating psychosis and substance dependence separately, demonstrate potential but have not been systematically evaluated when combined. Study Design Systematic review and random-effects meta-analyses of randomized controlled trials (RCTs) investigating PS interventions for individuals with comorbid substance use and psychotic disorders, encompassing SCZ and schizophrenia spectrum disorders (SSD). We included relevant studies published from MEDLINE, PsycINFO, and Google Scholar through May 2023. Study Results We included 35 RCTs (5176 participants total; approximately 2840 with SSD). Intervention durations ranged from 30 min to 3 years. Meta-analysis did not identify a statistically significant pooled PS intervention effect on the main primary outcome, substance use (18 studies; 803 intervention, 733 control participants; standardized mean difference, −0.05 standard deviation [SD]; 95% CI, −0.16, 0.07 SD; I2 = 18%). PS intervention effects on other outcomes were also not statistically significant. Overall GRADE certainty of evidence was low. Conclusions At present, the literature lacks sufficient evidence supporting the use of PS interventions as opposed to alternative therapeutic approaches for significantly improving substance use, symptomatology, or functioning in people with SCZ and related disorders. However, firm conclusions were precluded by low certainty of evidence. Further RCTs are needed to determine the efficacy of PS treatments for people with dual-diagnoses (DD), either alone or in combination with pharmacotherapy.","PeriodicalId":21530,"journal":{"name":"Schizophrenia Bulletin","volume":null,"pages":null},"PeriodicalIF":6.6,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141462679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Schizophrenia Bulletin
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1